Maxgalin ER 100 Tablet contains Pregabalin 100mg, an anticonvulsant and neuropathic pain agent indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, and spinal cord injury. It is also prescribed as adjunctive therapy for partial onset seizures in adults and for the treatment of generalized anxiety disorder. Pregabalin acts by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, thereby modulating calcium influx and reducing the release of excitatory neurotransmitters such as glutamate, norepinephrine, and substance P. Maxgalin ER 100 Tablet is formulated for extended-release, allowing for once-daily dosing which improves patient compliance and maintains stable plasma concentrations. Common adverse effects may include dizziness, somnolence, dry mouth, edema, and weight gain. It is contraindicated in patients with known hypersensitivity to pregabalin or any of its excipients. Caution is advised in patients with renal impairment, as dose adjustment may be necessary. Pregabalin should be used under strict medical supervision, and abrupt discontinuation should be avoided to prevent withdrawal symptoms. Maxgalin ER 100 Tablet offers effective symptom relief in neuropathic conditions and seizure disorders, contributing to improved quality of life.